Boehringer Ingelheim: Shashank Deshpande to lead Human Pharma business unit, Carinne Brouillon to retire
Ingelheim: Boehringer Ingelheim has announced that Shashank Deshpande, member of the Board of Managing Directors with responsibility for the Animal Health Business Unit, has been appointed to lead the Human Pharma Business Unit, effective October 1, 2024. Shashank Deshpande joined the Board of Managing Directors on September 1, 2023.
This came after Carinne Brouillon, member of the Board of Managing Directors with responsibility for the Human Pharma Business Unit, has informed the Shareholders of her intention to retire from the company per October 1, 2024.
Dr. Armin Wiesler, Regional Managing Director and Head of Animal Health for Southeast Asia, Korea, Australia and New Zealand has been appointed a member of the Board of Managing Directors, effective October 1, 2024. He will succeed Shashank Deshpande to lead the Animal Health Business Unit from this date.
Christian Boehringer, Chairman of the Shareholders’ Committee commented, “I would like to thank Carinne for her leadership and for transforming our Human Pharma business to prepare the organization to launch our rich pipeline in the coming years. Her collegiality, positivity and patient-first mindset were felt throughout our organization.”
Read Also: Alembic Pharma secures USFDA approval for Dabigatran Etexilate Capsules
The Company was founded in 1885. The Company serves over 130 markets in the two business units Human Pharma and Animal Health.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.